Cervical cancer: Clinical practice guidelines in oncology

Benjamin E. Greer, Wui Jin Koh, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Warner K. Huh, Daniel S. Kapp, John R. Lurain, Lainie Martin, Mark A. Morgan, Robert J. Morgan, David Mutch, Steven W. RemmengaR. Kevin Reynolds, William Small, Nelson Teng, Fidel A. Valea

Research output: Contribution to journalReview articlepeer-review

63 Scopus citations


Cervical cancer is decreasing in the United States because of the wide use of screening; however, it is increasing in developing countries (∼270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (including surgery and concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I-II) and in 60% of women with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of the virus, and will therefore prevent specific HPV cancer in women.

Original languageEnglish
Pages (from-to)1388-1416
Number of pages29
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number12
StatePublished - Dec 1 2010


  • Cervical cancer
  • Chemotherapy
  • Human papillomavirus
  • Hysterectomy
  • NCCN clinical practice guidelines
  • NCCN guidelines
  • Radiation therapy


Dive into the research topics of 'Cervical cancer: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this